Venetoclax Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 50 mg, 100 mg

Reference Brands: Venclexta® (EU & US)

Category: Oncology Cancer Care

Venetoclax is available in Tablet and strengths such as 10 mg, 50 mg, 100 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Venetoclax is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Venetoclax can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Venetoclax Tablets are a targeted oral therapy used in the treatment of hematologic malignancies such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML). As a potent BCL-2 inhibitor, Venetoclax promotes apoptosis in cancer cells by restoring programmed cell death pathways. Marketed under the brand name Venclexta®, it is available in 10 mg, 50 mg, and 100 mg strengths. Manufactured under GMP-certified facilities, Venetoclax offers a reliable oncology solution for B2B pharmaceutical partners across the US and EU, supporting effective cancer treatment strategies with proven clinical outcomes.